✦ LIBER ✦

Pre-operative concomitant hyperfractionated radiotherapy and gemcitabine (gemzar®)(gem) for locally advanced rectal cancer: a phase I–II trial

✍ Scribed by Allal, A.S.; Bieri, S.; Brundler, M.A.; Soravia, C.; Marti, M.C.; Gertsch, P.; Bernier, J.; Morel, P.; Roth, A.D.

Book ID: 122448322
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 194 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(01)81634-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine (GEM) and capecitabine (CAP)

Gemcitabine (GEM) and capecitabine (CAP) for advanced pancreatic cancer. A phase I/II trial

✍ Hess, V.; Bomer, M.; Morant, R.; Roth, A.D.; Ludwig, C.; Herman, R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Phase II Trial of Neoadjuvant Bevacizuma

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

✍ Christopher H. Crane; Cathy Eng; Barry W. Feig; Prajnan Das; John M. Skibber; Ge 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Hyperfractionated, accelerated radiother

Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: Quality of life in a prospective phase I/II trial

✍ Jolie Ringash; Gina Lockwood; Brian O’Sullivan; Padraig Warde; Andrew Bayley; Be 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 99 KB

A phase I trial of preoperative radiothe

A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer

✍ Ngan, S Y K; Michael, M; Mackay, J; McKendrick, J; Leong, T; Lim Joon, D; Zalcbe 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

Pre-operative bevacizumab, capecitabine,

Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial

✍ Hagen Kennecke; Scott Berry; Ralph Wong; Chen Zhou; Keith Tankel; Jacob Easaw; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Neurotoxicity in a phase I trial of cont

Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer

✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which